[{"address1": "789 West Pender Street", "address2": "Suite 810", "city": "Vancouver", "state": "BC", "zip": "V6C 1H2", "country": "Canada", "phone": "720-277-9879", "website": "https://www.mydecine.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. David Joshua Bartch", "age": 35, "title": "Co-Founder, CEO, President & Chairman of the Board", "yearBorn": 1988, "fiscalYear": 2022, "totalPay": 330372, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Roscow M.A.", "title": "Co-Founder, Chief Scientific Officer & Director", "fiscalYear": 2022, "totalPay": 338393, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Damon  Michaels", "title": "Co-Founder & COO", "fiscalYear": 2022, "totalPay": 338393, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Charles Ross CA, CPA, M.B.A.", "age": 65, "title": "CFO & Corporate Secretary", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": 6838, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sanford M. Stein", "title": "Chief Compliance Officer & General Counsel", "fiscalYear": 2022, "totalPay": 235864, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rakesh  Jetly FRCPC, M.D.", "title": "Chief Medical Officer", "fiscalYear": 2022, "totalPay": 201559, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Morgan  Kervitsky", "title": "Director of Marketing", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michel  Rudolphie", "title": "President of the European Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. William  Cook", "title": "Interim CEO & Technical Director of Mindleap Health Inc.", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.0125, "open": 0.013, "dayLow": 0.013, "dayHigh": 0.013, "regularMarketPreviousClose": 0.0125, "regularMarketOpen": 0.013, "regularMarketDayLow": 0.013, "regularMarketDayHigh": 0.013, "beta": 3.175, "forwardPE": 0.0052, "volume": 509, "regularMarketVolume": 509, "averageVolume": 30185, "averageVolume10days": 68970, "averageDailyVolume10Day": 68970, "marketCap": 781375, "fiftyTwoWeekLow": 0.008, "fiftyTwoWeekHigh": 0.656, "fiftyDayAverage": 0.04872, "twoHundredDayAverage": 0.139485, "currency": "USD", "enterpriseValue": 6169532, "floatShares": 50873209, "sharesOutstanding": 52567500, "heldPercentInsiders": 0.01131, "impliedSharesOutstanding": 60105800, "bookValue": -0.144, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -18067758, "trailingEps": -0.89, "forwardEps": 2.5, "lastSplitFactor": "1:45", "lastSplitDate": 1554076800, "enterpriseToEbitda": -0.456, "52WeekChange": -0.9723404, "SandP52WeekChange": 0.20883334, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "MYCOF", "underlyingSymbol": "MYCOF", "shortName": "MYDECINE INNOVATIONS GROUP INC ", "longName": "Mydecine Innovations Group Inc.", "firstTradeDateEpochUtc": 1610116200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ec001027-0d3b-362e-98f3-77c864913150", "messageBoardId": "finmb_286101205", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.013, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 17339, "ebitda": -13521770, "totalDebt": 5503494, "quickRatio": 0.021, "currentRatio": 0.713, "returnOnAssets": -2.0241702, "freeCashflow": -7137217, "operatingCashflow": -6418291, "financialCurrency": "CAD", "trailingPegRatio": null}]